257 research outputs found
Binder-Free Carbon Nanotube Electrode for Electrochemical Removal of Chromium
Electrochemical treatment of chromium-containing
wastewater has
the advantage of simultaneously reducing hexavalent chromium (Cr<sup>VI</sup>) and reversibly adsorbing the trivalent product (Cr<sup>III</sup>), thereby minimizing the generation of waste for disposal
and providing an opportunity for resource reuse. The application of
electrochemical treatment of chromium is often limited by the available
electrochemical surface area (ESA) of conventional electrodes with
flat surfaces. Here, we report the preparation and evaluation of carbon
nanotube (CNT) electrodes consisting of vertically aligned CNT arrays
directly grown on stainless steel mesh (SSM). We show that the 3-D
organization of CNT arrays increases ESA up to 13 times compared to
SSM. The increase of ESA is correlated with the length of CNTs, consistent
with a mechanism of roughness-induced ESA enhancement. The increase
of ESA directly benefits Cr<sup>VI</sup> reduction by proportionally
accelerating reduction without compromising the electrode’s
ability to adsorb Cr<sup>III</sup>. Our results suggest that the rational
design of electrodes with hierarchical structures represents a feasible
approach to improve the performance of electrochemical treatment of
contaminated water
Chemical Bath Deposition of Aluminum Oxide Buffer on Curved Surfaces for Growing Aligned Carbon Nanotube Arrays
Direct growth of vertically aligned
carbon nanotube (CNT) arrays
on substrates requires the deposition of an aluminum oxide buffer
(AOB) layer to prevent the diffusion and coalescence of catalyst nanoparticles.
Although AOB layers can be readily created on flat substrates using
a variety of physical and chemical methods, the preparation of AOB
layers on substrates with highly curved surfaces remains challenging.
Here, we report a new solution-based method for preparing uniform
layers of AOB on highly curved surfaces by the chemical bath deposition
of basic aluminum sulfate and annealing. We show that the thickness
of AOB layer can be increased by extending the immersion time of a
substrate in the chemical bath, following the classical Johnson–Mehl–Avrami–Kolmogorov
crystallization kinetics. The increase of AOB thickness in turn leads
to the increase of CNT length and the reduction of CNT curviness.
Using this method, we have successfully synthesized dense aligned
CNT arrays of micrometers in length on substrates with highly curved
surfaces including glass fibers, stainless steel mesh, and porous
ceramic foam
Image5_Systematic Elucidation of the Aneuploidy Landscape and Identification of Aneuploidy Driver Genes in Prostate Cancer.TIF
Aneuploidy is widely identified as a remarkable feature of malignancy genomes. Increasing evidences suggested aneuploidy was involved in the progression and metastasis of prostate cancer (PCa). Nevertheless, no comprehensive analysis was conducted in PCa about the effects of aneuploidy on different omics and, especially, about the driver genes of aneuploidy. Here, we validated the association of aneuploidy with the progression and prognosis of PCa and performed a systematic analysis in mutation profile, methylation profile, and gene expression profile, which detailed the molecular process aneuploidy implicated. By multi-omics analysis, we managed to identify 11 potential aneuploidy driver genes (GSTM2, HAAO, C2orf88, CYP27A1, FAXDC2, HFE, C8orf88, GSTP1, EFS, HIF3A, and WFDC2), all of which were related to the development and metastasis of PCa. Meanwhile, we also found aneuploidy and its driver genes were correlated with the immune microenvironment of PCa. Our findings could shed light on the tumorigenesis of PCa and provide a better understanding of the development and metastasis of PCa; additionally, the driver genes could be promising and actionable therapeutic targets pointing to aneuploidy.</p
Image6_Systematic Elucidation of the Aneuploidy Landscape and Identification of Aneuploidy Driver Genes in Prostate Cancer.TIF
Aneuploidy is widely identified as a remarkable feature of malignancy genomes. Increasing evidences suggested aneuploidy was involved in the progression and metastasis of prostate cancer (PCa). Nevertheless, no comprehensive analysis was conducted in PCa about the effects of aneuploidy on different omics and, especially, about the driver genes of aneuploidy. Here, we validated the association of aneuploidy with the progression and prognosis of PCa and performed a systematic analysis in mutation profile, methylation profile, and gene expression profile, which detailed the molecular process aneuploidy implicated. By multi-omics analysis, we managed to identify 11 potential aneuploidy driver genes (GSTM2, HAAO, C2orf88, CYP27A1, FAXDC2, HFE, C8orf88, GSTP1, EFS, HIF3A, and WFDC2), all of which were related to the development and metastasis of PCa. Meanwhile, we also found aneuploidy and its driver genes were correlated with the immune microenvironment of PCa. Our findings could shed light on the tumorigenesis of PCa and provide a better understanding of the development and metastasis of PCa; additionally, the driver genes could be promising and actionable therapeutic targets pointing to aneuploidy.</p
Image1_Systematic Elucidation of the Aneuploidy Landscape and Identification of Aneuploidy Driver Genes in Prostate Cancer.TIF
Aneuploidy is widely identified as a remarkable feature of malignancy genomes. Increasing evidences suggested aneuploidy was involved in the progression and metastasis of prostate cancer (PCa). Nevertheless, no comprehensive analysis was conducted in PCa about the effects of aneuploidy on different omics and, especially, about the driver genes of aneuploidy. Here, we validated the association of aneuploidy with the progression and prognosis of PCa and performed a systematic analysis in mutation profile, methylation profile, and gene expression profile, which detailed the molecular process aneuploidy implicated. By multi-omics analysis, we managed to identify 11 potential aneuploidy driver genes (GSTM2, HAAO, C2orf88, CYP27A1, FAXDC2, HFE, C8orf88, GSTP1, EFS, HIF3A, and WFDC2), all of which were related to the development and metastasis of PCa. Meanwhile, we also found aneuploidy and its driver genes were correlated with the immune microenvironment of PCa. Our findings could shed light on the tumorigenesis of PCa and provide a better understanding of the development and metastasis of PCa; additionally, the driver genes could be promising and actionable therapeutic targets pointing to aneuploidy.</p
Image4_Systematic Elucidation of the Aneuploidy Landscape and Identification of Aneuploidy Driver Genes in Prostate Cancer.TIF
Aneuploidy is widely identified as a remarkable feature of malignancy genomes. Increasing evidences suggested aneuploidy was involved in the progression and metastasis of prostate cancer (PCa). Nevertheless, no comprehensive analysis was conducted in PCa about the effects of aneuploidy on different omics and, especially, about the driver genes of aneuploidy. Here, we validated the association of aneuploidy with the progression and prognosis of PCa and performed a systematic analysis in mutation profile, methylation profile, and gene expression profile, which detailed the molecular process aneuploidy implicated. By multi-omics analysis, we managed to identify 11 potential aneuploidy driver genes (GSTM2, HAAO, C2orf88, CYP27A1, FAXDC2, HFE, C8orf88, GSTP1, EFS, HIF3A, and WFDC2), all of which were related to the development and metastasis of PCa. Meanwhile, we also found aneuploidy and its driver genes were correlated with the immune microenvironment of PCa. Our findings could shed light on the tumorigenesis of PCa and provide a better understanding of the development and metastasis of PCa; additionally, the driver genes could be promising and actionable therapeutic targets pointing to aneuploidy.</p
Image3_Systematic Elucidation of the Aneuploidy Landscape and Identification of Aneuploidy Driver Genes in Prostate Cancer.TIF
Aneuploidy is widely identified as a remarkable feature of malignancy genomes. Increasing evidences suggested aneuploidy was involved in the progression and metastasis of prostate cancer (PCa). Nevertheless, no comprehensive analysis was conducted in PCa about the effects of aneuploidy on different omics and, especially, about the driver genes of aneuploidy. Here, we validated the association of aneuploidy with the progression and prognosis of PCa and performed a systematic analysis in mutation profile, methylation profile, and gene expression profile, which detailed the molecular process aneuploidy implicated. By multi-omics analysis, we managed to identify 11 potential aneuploidy driver genes (GSTM2, HAAO, C2orf88, CYP27A1, FAXDC2, HFE, C8orf88, GSTP1, EFS, HIF3A, and WFDC2), all of which were related to the development and metastasis of PCa. Meanwhile, we also found aneuploidy and its driver genes were correlated with the immune microenvironment of PCa. Our findings could shed light on the tumorigenesis of PCa and provide a better understanding of the development and metastasis of PCa; additionally, the driver genes could be promising and actionable therapeutic targets pointing to aneuploidy.</p
Hierarchical Carbon Nanotube Membrane-Supported Gold Nanoparticles for Rapid Catalytic Reduction of <i>p</i>‑Nitrophenol
Gold
nanoparticles (AuNPs) have attracted increasing attention
as catalysts for pollutant degradation because of their unique reactivity.
Direct use of gold nanoparticles in water treatment faces prohibitive
challenges from nanoparticle aggregation and post-treatment separation.
To prevent nanoparticles from aggregating and eliminate the need for
separation, we affixed AuNPs on hierarchical carbon nanotube membrane
(HCNM) that was approximately 50 μm thin with 10 μm ×
10 μm openings as pores for water passage. HCNM was fabricated
by growing vertically aligned carbon nanotube (CNT) arrays on stainless
steel mesh. Using p-nitrophenol (PNP) as model pollutant,
we showed that in batch experiments HCNM-supported AuNPs retained
78% of their catalytic capability compared to suspended AuNPs. The
slight reduction in reactivity was attributed to the blockage of part
of the gold surface at the AuNP–CNT juncture. When the membrane
was used in continuous flow-through operation, HCNM-supported AuNPs
achieved 71% of the maximum catalytic ability measured in batch. The
rapid kinetics obtained with HCNM-supported AuNPs was in great contrast
to the slow kinetics that one would expect for a rigid membrane of
similar configuration. For a rigid membrane, water passing through
microscopic pores was confined as laminar flow and thus would not
mix well with catalysts affixed on pore walls. For HCNM, CNTs aligning
pore walls were flexible so that they could move vigorously to create
a chaotic mixing condition and promote AuNP-catalyzed PNP reduction
Image2_Systematic Elucidation of the Aneuploidy Landscape and Identification of Aneuploidy Driver Genes in Prostate Cancer.TIF
Aneuploidy is widely identified as a remarkable feature of malignancy genomes. Increasing evidences suggested aneuploidy was involved in the progression and metastasis of prostate cancer (PCa). Nevertheless, no comprehensive analysis was conducted in PCa about the effects of aneuploidy on different omics and, especially, about the driver genes of aneuploidy. Here, we validated the association of aneuploidy with the progression and prognosis of PCa and performed a systematic analysis in mutation profile, methylation profile, and gene expression profile, which detailed the molecular process aneuploidy implicated. By multi-omics analysis, we managed to identify 11 potential aneuploidy driver genes (GSTM2, HAAO, C2orf88, CYP27A1, FAXDC2, HFE, C8orf88, GSTP1, EFS, HIF3A, and WFDC2), all of which were related to the development and metastasis of PCa. Meanwhile, we also found aneuploidy and its driver genes were correlated with the immune microenvironment of PCa. Our findings could shed light on the tumorigenesis of PCa and provide a better understanding of the development and metastasis of PCa; additionally, the driver genes could be promising and actionable therapeutic targets pointing to aneuploidy.</p
- …
